CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Lab123, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Lab123, Inc.
100 Field Drive
Suite 240
Phone: (847) 234-8111p:847 234-8111 Lake Forest, 60045  United States

Business Summary
Lab123, Inc. (Lab123) is a development stage company. The Company is a marketing, distributing and manufacturing company whose objective is to license, broker or acquire retail medical diagnostic products and services to sell into retail drug stores and chains in the United States and to Internet drug retailers. It is engaged in the marketing of clinical diagnostic products for use in disease detection and prevention. Under the license agreement with Biosafe Laboratories, Inc. (Biosafe), the Company sells diagnostic products to retail drug stores, retail drug mass merchandisers, and the distributors, marketers, brokers and group buyers who supply medical products to retail drug stores, retail drug mass merchandisers in the United States and to Internet-based retail drug companies. Its products specialize in the use of micro-sample blood transportation devices and scientific procedures for the clinical testing of these micro-blood samples.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/200712/31/2006YesYes---

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board HenryWarner 65 8/1/2006 8/1/2006
Executive Vice President Ernest R.Azua 70 3/1/2007 3/1/2007
Director Michael J.Carney 67 3/1/2007 3/1/2007
Director KentConnally 64 9/1/2006 9/1/2006
Director KurtKatz 78 9/1/2006 9/1/2006

General Information
Outstanding Shares: 9,949,000 (As of 1/17/2008)
Federal Tax Id: 450542515


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, August 30, 2023